البلد: الولايات المتحدة
اللغة: الإنجليزية
المصدر: NLM (National Library of Medicine)
gemcitabine hydrochloride (UNII: U347PV74IL) (gemcitabine - UNII:B76N6SBZ8R)
hameln rds gmbh
gemcitabine hydrochloride
gemcitabine 200 mg in 5 mL
PRESCRIPTION DRUG
Abbreviated New Drug Application
GEMCITABINE HYDROCHLORIDE- GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION HAMELN RDS GMBH ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE GEMCITABINE FOR INJECTION USP SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR GEMCITABINE FOR INJECTION USP. GEMCITABINE FOR INJECTION USP (GEMCITABINE FOR INJECTION) POWDER, LYOPHILIZED, FOR SOLUTION FOR INTRAVENOUS USE INITIAL U.S. APPROVAL: 1996 INDICATIONS AND USAGE Gemcitabine for Injection USP is a nucleoside metabolic inhibitor indicated for: Ovarian cancer in combination with carboplatin (_1.1_) Breast cancer in combination with paclitaxel (_1.2_) Non-small cell lung cancer in combination with cisplatin (_1.3_) Pancreatic cancer as a single-agent (_1.4_) DOSAGE AND ADMINISTRATION Gemcitabine for Injection USP is for intravenous use only. Ovarian cancer: 1000 mg/m over 30 minutes on Days 1 and 8 of each 21-day cycle (_2.1_) Breast cancer: 1250 mg/m over 30 minutes on Days 1 and 8 of each 21-day cycle (_2.2_) Non-small cell lung cancer: 4-week schedule; 1000 mg/m over 30 minutes on Days 1, 8, and 15 of each 28-day cycle: 3-week schedule; 1250 mg/m over 30 minutes on Days 1 and 8 of each 21-day cycle (_2.3_) Pancreatic cancer: 1000 mg/m over 30 minutes once weekly for up to 7 weeks (or until toxicity necessitates reducing or holding a dose), followed by a week of rest from treatment. Subsequent cycles should consist of infusions once weekly for 3 consecutive weeks out of every 4 weeks (_2.4_) Dose Reductions or discontinuation may be needed based on toxicities (_2.1-2.4_) DOSAGE FORMS AND STRENGTHS 200 mg vial for injection (_3_) 1 g vial for injection (_3_) CONTRAINDICATIONS Patients with a known hypersensitivity to gemcitabine (_4_) WARNINGS AND PRECAUTIONS Infusion time and dose frequency: Increased toxicity with infusion time >60 minutes or dosing more frequently than once weekly. (_5.1_) Hematology: Monitor for myelosuppression, which can be dose-limiting. (_5.2, 5. اقرأ الوثيقة كاملة